| 365 Mdcare Inc | |
|
9041 Magnolia Ave Suite 302 Riverside CA 92503-3900 | |
| (951) 637-9999 | |
| Not Available |
| Full Name | 365 Mdcare Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 9041 Magnolia Ave, Riverside, California |
| Authorized Official Name and Position | Robert Nguyen (PRESIDENT) |
| Authorized Official Contact | 9516379999 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| 365 Mdcare Inc 15777 S Cliff Ct Riverside CA 92503-5493 Ph: (951) 637-9999 | 365 Mdcare Inc 9041 Magnolia Ave Suite 302 Riverside CA 92503-3900 Ph: (951) 637-9999 |
| NPI Number | 1164869780 |
|---|---|
| Provider Enumeration Date | 05/23/2013 |
| Last Update Date | 04/30/2020 |
| Medicare PECOS PAC ID | 8224271887 |
|---|---|
| Medicare Enrollment ID | O20130829000269 |
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164869780 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Robert W Nguyen |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1144256900 PECOS PAC ID: 8325052228 Enrollment ID: I20060131000232 |
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
| Provider Name | Son N Nguyen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376593889 PECOS PAC ID: 3577519404 Enrollment ID: I20081211000055 |
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
| Provider Name | Norman K Orr |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871859553 PECOS PAC ID: 7810214715 Enrollment ID: I20150401002297 |
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
| Provider Name | Huynh Ngoc Tu Nguyen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750932141 PECOS PAC ID: 3971936204 Enrollment ID: I20191127001279 |
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
News Archive
NanoViricides, Inc., announced today that it has raised $5,000,000, drawing down on its previously announced universal registered shelf "Form S-3" offering. The registered shelf offering became effective on April 29, 2010.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Sandlot - a clinical health information technology company founded by practicing physicians - has partnered with TactusMD Inc. - a physician-owned electronic health record (EHR) solutions company based in Marietta, Georgia. The two physician-governed companies will offer tailored, integrated EHR and HIE service solutions to maximize patient care and business efficiencies for pediatric practices, hospitals and health plans.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
› Verified 5 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |